PAVmed Names Shaun O’Neil Chief Commercial Officer
PAVmed Inc. (PAVM)
US:NASDAQ Investor Relations:
ir.pavm.com
Company Research
Source: Business Wire
Medical device veteran joins as company approaches important regulatory and commercial milestones Immediate focus on building commercialization platforms for CarpX and EsoCheck NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that it has named Shaun M. O’Neil to serve as its first Chief Commercial Officer. Mr. O’Neil will oversee all aspects of the domestic and international commercialization of PAVmed’s products including sales and marketing, clinician engagement and professional education. He will officially assume his role on July 23 reporting directly to Lishan Aklog, M.D., PAVmed’s Chairman and Chief Executive Officer. “I am incredibly excited to welcome Shaun O’Neil to the PAVmed team,” said Dr Aklog. “As PAVmed approaches important regulatory and commercial m
Show less
Read more
Impact Snapshot
Event Time:
PAVM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PAVM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PAVM alerts
High impacting PAVmed Inc. news events
Weekly update
A roundup of the hottest topics
PAVM
News
- PAVmed (NASDAQ:PAVM) had its price target lowered by analysts at Ascendiant Capital Markets from $20.00 to $17.00. They now have a "buy" rating on the stock.MarketBeat
- PAVmed Inc. (PAVM) Shareholder/Analyst Call Prepared Remarks Transcript [Seeking Alpha]Seeking Alpha
- PAVmed (NASDAQ:PAVM) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.MarketBeat
- PAVmed Inc. (PAVM) Q3 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum [Yahoo! Finance]Yahoo! Finance
PAVM
Earnings
- 11/13/25 - Beat
PAVM
Sec Filings
- 12/5/25 - Form 8-K
- 11/13/25 - Form 8-K
- 11/12/25 - Form 10-Q
- PAVM's page on the SEC website